Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Rosenstein

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|April 1, 2011
Cardiac-resynchronization therapyRobert S Rosenstein, David Parra
Circulation|July 1, 2009
Letter by Rosenstein and Parra regarding article, "Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel: Thrombolysis in Myocardial Infarction 38"Robert S Rosenstein, David Parra
The New England Journal of Medicine|January 6, 2010
Ticagrelor versus clopidogrel in acute coronary syndromesRobert S Rosenstein, David Parra
JAMA|November 19, 2009
Biomarkers for prediction of cardiovascular eventsRobert S Rosenstein, David Parra
Circulation|January 25, 2012
Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial"Stephanie Reynolds, David Parra, Robert S Rosenstein
Pharmacotherapy|March 9, 2013
Acute myocardial infarction during regadenoson myocardial perfusion imagingSachil Shah, David Parra, Robert S Rosenstein
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 9, 2015
Use of apixaban after development of suspected rivaroxaban-induced hepatic steatosis; a case reportEmily J Anastasia, Robert S Rosenstein, Jeffrey A Bergsman, et al.
JACC. Cardiovascular Interventions|May 6, 2017
Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve ReplacementBrandon E Cave, Augustus R Hough, David Parra, et al.
Acta Cardiologica|June 10, 2017
Ultrafiltration versus intravenous loop diuretics in patients with acute decompensated heart failure: a meta-analysis of clinical trialsMohamad Kabach, Hassan Alkhawam, Sachil Shah, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|April 1, 2011
Cardiac-resynchronization therapyRobert S Rosenstein, David Parra
Circulation|July 1, 2009
Letter by Rosenstein and Parra regarding article, "Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel: Thrombolysis in Myocardial Infarction 38"Robert S Rosenstein, David Parra
The New England Journal of Medicine|January 6, 2010
Ticagrelor versus clopidogrel in acute coronary syndromesRobert S Rosenstein, David Parra
JAMA|November 19, 2009
Biomarkers for prediction of cardiovascular eventsRobert S Rosenstein, David Parra
Circulation|January 25, 2012
Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial"Stephanie Reynolds, David Parra, Robert S Rosenstein
Pharmacotherapy|March 9, 2013
Acute myocardial infarction during regadenoson myocardial perfusion imagingSachil Shah, David Parra, Robert S Rosenstein
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 9, 2015
Use of apixaban after development of suspected rivaroxaban-induced hepatic steatosis; a case reportEmily J Anastasia, Robert S Rosenstein, Jeffrey A Bergsman, et al.
JACC. Cardiovascular Interventions|May 6, 2017
Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve ReplacementBrandon E Cave, Augustus R Hough, David Parra, et al.
Acta Cardiologica|June 10, 2017
Ultrafiltration versus intravenous loop diuretics in patients with acute decompensated heart failure: a meta-analysis of clinical trialsMohamad Kabach, Hassan Alkhawam, Sachil Shah, et al.
Pageof 1